Good MorningEquities rebounded again on Wednesday gaining about 2.0% at the height of the session. The move was driven by better than expected data on the labor front as well as some less-hawkish than expected comments from Jerome Powell. On the labor front, the ADP employment report showed the addition of more than 1.0 million new jobs to the economy when adjusted for revisions. The data is more than double the expectations and points to even tighter labor market conditions than previously thought. The NFP is due out on Friday and could reveal the same information. The risk with the NFP is that wage gains are expected to top 6.0% on a YOY basis and drive consumer-level inflation this year.
Elsewhere in the markets, the price of West Texas Intermediate surged more than 3.0% on Wednesday to above $113 per barrel. This is the highest level for WTI in over a decade and prices are expected to keep rising. Based on the technical outlook, the price of WTI will move above $120 very soon and will be another driving force of inflation this year. Featured: Watch These 5 Megatrend Stocks (PTR) 
|
Politics | | | Global stock markets were mixed Thursday and oil prices jumped another $5 as Russian forces whose attack on Ukraine has roiled financial markets bombarded the country’s second-largest city and besieged two ports.
The economic fallout from the Russian invasion expanded, with Fitch Rati... Read the Full Story |
|
From Our PartnersExpert predicts an announcement scheduled for March16th, 2022, could have many Americans unloading their investments and running to the bank. With just one move, the most popular asset in America could suddenly be on its way to being illegal. | | Click here to see how you can protect your family and wealth. |
|
Markets | | | Even blue chip names such as those in the Dow Jones index have been unusually volatile in recent days. For the long-term investor, it means quality stocks like The Home Depot, NIKE, and 3M are now worth invading. Read the Full Story |
|
Markets | | | As we move into the month of March, dividend stocks remain some of the strongest options to consider in the current market environment. Whether you are concerned about the impacts of inflation or simply want to own stocks that are known to hold up well during volatility, adding dividend-payers to your strategy Read the Full Story |
|
From Our PartnersInterested in the potential of the NFT market, but don't consider yourself a collector? Then investing in NFT stocks may be a better way to go... Check out these 3 NFT stocks well positioned to deliver high upside to investors over the next 12 to 18 months. | | >>> Click here to get the full details. |
|
Politics | | | The latest developments on the Russia-Ukraine war:
BRUSSELS — A senior European Union official says that in the wake of Ukraine’s formal application this week to join the bloc, bids for entry are also expected “imminently” from Moldova and Georgia.
The two eastern Europ... Read the Full Story |
|
Stocks | | | The analysts still love Salesforce.com (NYSE: CRM) despite the round of price target reductions it just received. The company reported a stellar quarter and raised its guidance but the analyst still felt the need to adjust their targets. Read the Full Story |
|
From Our PartnersThese 5 stocks offer the potential to deliver significant returns in the months ahead thanks to key megatrends... They are well-positioned to deliver a high upside to investors over the next 12 to 18 months. Don't miss out on your chance to get in early. | | Click here to get the names & ticker symbols of all 5 |
|
Politics | | | The latest developments on the Russia-Ukraine war:
PARIS — French authorities say they have seized a yacht linked to Igor Sechin, an ally of Russian President Vladimir Putin, as part of European Union sanctions over Russia’s invasion of Ukraine.
The French Finance Minis... Read the Full Story |
|
Politics | | | The latest developments on the Russia-Ukraine war:
MOSCOW — Russia’s foreign minister says Moscow is ready for peace talks but will press its effort to destroy Ukraine’s military infrastructure, which the Kremlin claims is threatening Russia.
Foreign Minister Sergey La... Read the Full Story |
|
Politics | | | China's ruling Communist Party is temporarily turning away from its longer-term ambitions to focus on pulling the economy out of a slump as the country heads into the annual meeting of its ceremonial legislature.
The National People's Congress, usually used to showcase big initiatives... Read the Full Story |
|
Stocks | | | Shares of Ross Stores (NASDAQ: ROST) are moving up because of a combination of factors that include performance, capital returns, and a greatly improved outlook for long-term growth. The company says that, due to changes within the industry, they are now forecasting as much as 20% more growth over the long term than they were previously. Read the Full Story |
|
Markets | | | Visual social media lifestyle brand platform Pinterest (NYSE: PINS) stock has fallen over (-60%) off its pandemic highs of $90.09. To the disappointment of investors, the Company experienced a (-6%) drop in monthly active users (MAUs) despite having 431 million worldwide users in Q4 2021. While Pint... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States. The company discovers, develops, and commercializes novel and small molecule Selective Inhibitor of Nuclear Export (SINE) compounds that inhibit the nuclear export protein exportin 1 (XPO1). Its lead compound, include XPOVIO in combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma; in combination with dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma; and for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). It also developing Selinexor for treating hematological and solid tumor malignancies, including multiple myeloma, endometrial cancer, myelofibrosis, and DLBCL; and ELTANEXOR for treating Myelodysplastic Neoplasms, as well as verdinexor, KPT-9274, and IL-12 compounds. The company has license agreement with Menarini Group to develop and commercialize selinexor for human oncology indications; license agreement with Antengene Therapeutics Limited to develop and commercialize selinexor, eltanexor, and KPT-9274 for the treatment and/or prevention of human oncology indications, as well as verdinexor for the diagnosis, treatment, and/or prevention of human non-oncology indications; and distribution agreement for the commercialization of XPOVIO with FORUS Therapeutics Inc. Further, it has a collaboration with Bristol Myers Squibb company to evaluate novel cereblon E3 ligase modulator agent mezigdomide in combination with Selinexor in patients with relapsed/refractory multiple myeloma. Karyopharm Therapeutics Inc. was incorporated in 2008 and is headquartered in Newton, Massachusetts. | | View Today's Stock Pick |
|
